Targeting Intratibial Osteosarcoma Using Water-Soluble Copolymers Conjugated to Collagen Hybridizing Peptides

Area of Science:

• Oncology
• Biomaterials Science
• Nanotechnology

Background:

• Osteosarcoma (OS) is a primary bone cancer common in adolescents.
• Current chemotherapy for OS has limitations including toxicity and poor tumor localization.
• Denatured collagen is abundant in OS tumors, presenting a potential therapeutic target.

Purpose of the Study:

• To develop and evaluate HPMA copolymer-CHP conjugates for targeted delivery to OS tumors.
• To assess the accumulation and retention of targeted conjugates in a murine OS model.
• To correlate copolymer accumulation with bone microarchitecture changes.

Main Methods:

• Conjugation of collagen hybridizing peptides (CHPs) to N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers.
• Evaluation of conjugate accumulation and retention in a murine intratibial OS tumor model.
• Microcomputed tomography (micro-CT) analysis of bone microarchitecture.

Main Results:

• HPMA copolymer-CHP conjugates demonstrated increased tumor accumulation compared to non-targeted copolymers.
• Targeted conjugates showed enhanced retention in OS tumors.
• Correlation established between copolymer accumulation and bone morphometric parameters.

Conclusions:

• HPMA copolymer-CHP conjugates are effective in targeting and accumulating in OS tumors.
• These targeted conjugates offer improved retention, suggesting potential for enhanced therapeutic efficacy.
• The findings support the use of HPMA copolymer-CHP conjugates as a targeted drug delivery system for osteosarcoma.